RedHill Biopharma Ltd.

RDHL | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.55

$0 (+0.02%)

At close: Sep 22, 2026, 3:59 PM ET

$0.54

-$0.01 (-1.65%)

After-hours: Sep 22, 2026, 7:18 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.02%

(1D)

Rating

Updated: Aug 14, 2026

27.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.73M

1D Range

0.52 0.57

52W Range

0.52 2.79

Valuation (TTM)

PE -0.14

PB 0.40

EV/EBITDA 0.15

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -475.1%

SBC Adj. FCF Yield -517.5%

SBC Impact -8.9%

Margins

Gross Margin 60.6%

Operating Margin -110.4%

FCF Margin -86.0%

Growth (CAGR)

Revenue 3Y | 5Y -49.7% | -17.5%

Dil EPS 3Y | 5Y 65.0% | 74.5%

FCF 3Y | 5Y 46.1% | 36.5%

Returns

ROA -16.3%

ROE 5740.3%

ROIC -69.6%

Financial Health

Net Cash

$3.97M

Current Ratio 0.34

Interest Coverage -4.28

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointes...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 13

IPO Date Jan 6, 2013

Website www.redhillbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Mar 18, 2027

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞